National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients With Type 2 Diabetes: The FINE-Asia Registry

Diabetes Therapy - United States
doi 10.1007/s13300-015-0137-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search